NxStage
From Wikipedia, the free encyclopedia
Company typeSubsidiary
IndustryMedical devices
FoundedDecember 1998
FounderC. David Finch, Jr., MD and Jeffrey H. Burbank
 | |
| Company type | Subsidiary |
|---|---|
| Industry | Medical devices |
| Founded | December 1998 |
| Founder | C. David Finch, Jr., MD and Jeffrey H. Burbank |
| Headquarters | , U.S. |
| Products | System One |
| Revenue |  $393 million (2017) |
| -$14 million (2017) | |
| Total assets | $325 million (2017) |
| Total equity | $213 million (2017) |
Number of employees | 3,800 (2017) |
| Parent | Fresenius Medical Care |
| Website | www |
| Footnotes / references [1] | |
NxStage Medical, Inc. (/ˈnɛkˌsteɪdʒ/ NEK-stayj[2]) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product.[1]